Our study suggests that AD pathology, particularly the accumulation of Aß plaque (but not the composition of the Aß plaque), induces a shift in the proportion of co-localized and non-colocalized p-tau217/p-tau231/p-tau205, and that this shift is dependent on the cellular environment of the phosphorylated tau. This evidence concerns the gene MAPT and Alzheimer disease.